Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 3rd quarter

<< Previous

Bullboard Posts

Next >>

Comment by 3Crowson Jun 27, 2024 10:59am

255 Views

Post# 36108878

RE:RE:RE:RE:RE:RE:RE:RE:RE:3rd quarter

@ NOtaPOOp: I have been here only a few short months. In that time, after having established a healthy position in TLT, I have read every post on this board. It did not take me long to discriminate who were the legitimate, intelligent, thought-provoking, informed, and respectful posters from those who were not. If one wants their voice heard, decorum and courtesy go a long way. (Having said that, I took my own advice and refrained from addressing you as NimcomPOOp.)

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading